BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3466 related articles for article (PubMed ID: 27638987)

  • 21. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes.
    Audibert F; De Bie I; Johnson JA; Okun N; Wilson RD; Armour C; Chitayat D; Kim R
    J Obstet Gynaecol Can; 2017 Sep; 39(9):805-817. PubMed ID: 28859766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound in twin pregnancies.
    Morin L; Lim K; ; ; ;
    J Obstet Gynaecol Can; 2011 Jun; 33(6):643-656. PubMed ID: 21846456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No. 380-Investigation and Management of Prenatally Identified Microcephaly.
    De Bie I; Boucoiran I
    J Obstet Gynaecol Can; 2019 Jun; 41(6):855-861. PubMed ID: 31126434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity in pregnancy.
    Davies GAL; Maxwell C; McLeod L; ;
    J Obstet Gynaecol Can; 2010 Feb; 32(2):165-173. PubMed ID: 20181319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guideline No. 392-Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care.
    Maxwell C; Gaudet L; Cassir G; Nowik C; McLeod NL; Jacob CÉ; Walker M
    J Obstet Gynaecol Can; 2019 Nov; 41(11):1660-1675. PubMed ID: 31640866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SOGC Guideline Retirement Notice No. 2.
    J Obstet Gynaecol Can; 2022 Oct; 44(10):1104-1112. PubMed ID: 36241341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal and perinatal autopsy in prenatally diagnosed fetal abnormalities with normal karyotype.
    Désilets V; Oligny LL; ; ;
    J Obstet Gynaecol Can; 2011 Oct; 33(10):1047-57. PubMed ID: 22014783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced reproductive age and fertility.
    Liu K; Case A;
    J Obstet Gynaecol Can; 2011 Nov; 33(11):1165-1175. PubMed ID: 22082792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carrier testing for autosomal-recessive disorders.
    Vallance H; Ford J
    Crit Rev Clin Lab Sci; 2003 Aug; 40(4):473-97. PubMed ID: 14582604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer, pregnancy, and breastfeeding.
    Helewa M; Lévesque P; Provencher D; Lea RH; Rosolowich V; Shapiro HM;
    J Obstet Gynaecol Can; 2002 Feb; 24(2):164-80; quiz 181-4. PubMed ID: 12196882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent.
    Obstet Gynecol; 2009 Oct; 114(4):950. PubMed ID: 19888064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.
    Capalbo A; Fabiani M; Caroselli S; Poli M; Girardi L; Patassini C; Favero F; Cimadomo D; Vaiarelli A; Simon C; Rienzi LF; Ubaldi FM
    Hum Reprod; 2021 Jun; 36(7):2050-2061. PubMed ID: 34021342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Umbilical Cord Blood: Counselling, Collection, and Banking.
    Armson BA; Allan DS; Casper RF
    J Obstet Gynaecol Can; 2015 Sep; 37(9):832-844. PubMed ID: 26605456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fragile X testing in obstetrics and gynaecology in Canada.
    Chitayat D; Wyatt PR; ;
    J Obstet Gynaecol Can; 2008 Sep; 30(9):837-841. PubMed ID: 18845054
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 174.